Markets in Financial Instruments Directive (MiFID)
The Markets in Financial Instruments Directive, universally known by its acronym MiFID, is the core piece of European Union legislation regulating investment firms, trading venues and the provision of financial services across the EU's single market. Its underlying purpose is to harmonize financial market rules across EU member states, so that an investment firm, broker or exchange operating under one country's MiFID-compliant license can offer services across the whole bloc under broadly consistent rules, while also strengthening investor protection and market transparency.
The original MiFID (formally Directive 2004/39/EC) was adopted by the EU in 2004 and came into force across member states on November 1, 2007. It set baseline requirements around firm authorization, conduct of business, and - one of its most cited provisions - best execution, requiring investment firms to take reasonable steps to obtain the best possible result for their clients when executing orders, considering price, cost, speed, likelihood of execution and settlement, not simply the first available price.
MiFID's scope proved too narrow as markets evolved - the original directive focused heavily on equities and left large parts of the bond, derivatives and commodities markets, along with newer electronic and algorithmic trading practices, comparatively lightly regulated. In response, the EU adopted a substantially expanded overhaul known as MiFID II (alongside a companion regulation, MiFIR), originally intended to take effect in January 2017 but delayed by a year due to the scale of the systems and reporting changes required, ultimately coming into force on January 3, 2018. MiFID II broadened the rules to cover a far wider range of financial instruments including bonds, derivatives and structured products; introduced detailed pre- and post-trade transparency requirements across more trading venues; tightened rules on algorithmic and high-frequency trading, including mandatory testing and circuit-breaker requirements; and, in one of its most disruptive practical changes for the asset management industry, required investment firms to "unbundle" the cost of investment research from trading commissions, forcing firms to pay for research separately and explicitly rather than folding it invisibly into trading costs - a change that reshaped how sell-side research is funded and consumed across the industry.
For traders, MiFID and MiFID II are most directly felt through the leverage caps and marketing restrictions retail brokers operate under across the EU - for example, the European Securities and Markets Authority's 2018 intervention, exercised under MiFID II's product intervention powers, capped retail forex leverage on major currency pairs at 30:1 and imposed mandatory negative balance protection and standardized risk warnings for CFD providers marketing to EU retail clients. The UK operated under MiFID II as an EU member until Brexit took effect, after which the UK "onshored" MiFID II's rules into UK domestic law as a starting baseline, with the UK's Financial Conduct Authority subsequently free to diverge from EU rules over time - a divergence regulators and market participants on both sides have watched closely since. The framework differs substantially from the US approach to market structure regulation, which relies on a different set of rules (including Regulation NMS for equities) developed under a separate regulatory history via the SEC and CFTC rather than MiFID's EU-wide directive model, meaning a firm operating across both the EU and US financial markets typically has to satisfy two structurally different, only partially overlapping sets of market-structure and transparency requirements.
The research provision has since become the clearest case of a MiFID rule retreating under the weight of its own consequences. Separating payment for analysis from payment for execution was supposed to expose what research actually cost. It did, and the immediate reaction of asset managers now paying out of their own profits was to buy far less of it. Coverage of small and mid-sized listed companies contracted first, because nobody was willing to fund analysis of shares that generated little commission, leaving a tier of the market less researched and therefore harder for any investor to value with confidence.
The episode is worth holding on to as a general lesson about market regulation rather than as a fact about research budgets. The rule did exactly what it was designed to do, and the cost fell on a group nobody had been thinking about when it was drafted: companies too small to generate the commissions that would pay for analysing them. Regulators in both London and Brussels have since amended the requirement, but the underlying point survives the amendment. Transparency about a price is not free; somebody was previously paying for the thing whose cost was hidden, and revealing the figure invites a decision about whether to keep buying it. Where the answer turns out to be no, the service disappears rather than merely becoming visible, and the parties who relied on it without knowing they were being subsidised find out only afterwards.